SP-D has been shown to induce apoptosis in vitro via the Fas-mediated pathway and inhibit TGF-β expression, thereby reducing invasive potential (22, 45, 113, 119); and it also induces cell cycle arrest in the G1 phase, limiting pancreatic cancer cell proliferation and inhibiting tumor growth. This evidence concerns the gene SFTPD and neoplasm.